Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines

Carcinogenesis

Volumn 18, Issue 7, 1997, Pages 1291-1297

  Macé, Katherine ^a   Aguilar, Fernando ^a   Wang, Jia Sheng ^b   Vautravers, Patricia ^a   Gómez Lechön, Maria ^c   Gonzalez, Frank J ^d   Groopman, John ^b   Harris, Curtis C ^e   Pfeifer, Andrea M A ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b The Johns Hopkins University   (United States)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CYTOCHROME P450 ISOENZYME; PROTEIN P53; AFLATOXIN B1 DNA ADDUCT; AFLATOXIN B1-DNA ADDUCT; CYTOCHROME P450;

ARTICLE; CELL IMMORTALIZATION; CODON; CONTROLLED STUDY; CYTOTOXICITY; DIET; DNA ADDUCT; ENZYME ACTIVITY; EPITHELIUM CELL; GENE FREQUENCY; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SIMIAN VIRUS 40; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; ADULT; CELL LINE; DRUG EFFECT; LIVER; METABOLISM; MUTATION; WESTERN BLOTTING;

ADULT; AFLATOXIN B1; BLOTTING, WESTERN; CELL LINE; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; GENES, P53; HUMANS; LIVER; MUTATION;

EID: 0031284677     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.7.1291     Document Type: Article

References (44)

1. Sun, T.T., Harris, C.C., Hui, F.W., Dridford, K. and Adamson, R.H. (1989) Proceedings of pathogenesis and prevention of hepatocellular carcinoma. Cancer Detec. Prev., 14, 191-315.
2. Harris, C.C. (1990) Hepatocellular carcinogenesis: recent advances and speculation. Cancer Cells, 2, 156-148.
3. Wild, C.P., Jansen, L.A.M., Cova, L. and Montesano, R. (1993) Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ. Hlth Perspect., 99, 115-122.
4. Ross, R.K., Yuan, J.-M., Yu, M.C., Wogan, G.N., Qian, G.-S., Tu, J.-T., Groopman, J.D., Gao, Y.-T. and Henderson, B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, i943-946.
5. Qian, G.-S., Ross, R.K., Yu, M.C., Yuan, J.-M., Gao, Y.-T., Hendenson, E., Wogan, G.N. and Groopman, J.D. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai people s Republic of China. Cancer Epidemiol. Biomarkers Prev., 3, 3-10.
6. Bressac, B., Kew, M., Wands, J. and Ozturk, M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature, 350, 429-431.
7. Soini, Y., Chia, S.C., Bennett, W.P., et al. (1996) An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis, 17, 1007-1012.
8. Harris, C.C. (1996) The 1995 Walter Hubert lecture-molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumor-suppressor gene. Br. J. Cancer, 73, 261-269.
9. Aguilar, F., Harris, C.C., Sun, T., Hollstein, M. and Cerutti, P. (1994) Geographic variation of p53 mutational profile in nonmalignant human liver Science 264, 1317-1319.
10. 1 in vitro. Proc. Natl Acad. Sci. USA, 80, 2695-2698.
11. 1 in a shuttle vector replicating in human cells transiently expressing cytochrome P4501A2 cDNA. Mol. Carcinogenesis, 6 140-147.
12. Cariello, N.F., Cui, L. and Skopek, T.R. (1994) In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyl-transferase gene. Cancer Res., 54, 4436-4441.
13. Puisieux, A., Lim, S., Groopman, J.D. and Ozturk, M. (1991 ) Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res., 51, 6185-6189.
14. 1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl Acad. Sci. USA, 90, 8586-8590.
15. 1. Proc. Natl Acad. Sci. USA, 87, 4790-4793.
16. Crespi, C.L., Penman, B.W., Leakey, J.A.E., et al. (1990) Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis, 11, 1293-1300.
17. 1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis, 12, 355-359.
18. Macé, K., Gonzalez, F.J. McConnell, I.R., Garner, R.C., Avanti, O., Harris, C.C. and Pfeifer, A.M.A. (1994) Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P450 1A2. Mol. Carcinogenesis, 11, 65-73.
19. 1 in vitro. Proc. Natl Acad. Sci. USA, 74, 1870-1874.
20. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F.P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414-423.
21. Shimada, T. and Guengerich, F.P. (1989) Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl Acad. Sci. USA, 86, 462-465.
22. Harris, C.C. (1989) Interindividual variations among humans in carcinogen metabolism. DNA adduct formation and DNA repair. Carcinogenesis, 10, 1563-1566.
23. Pfeifer, A.M.A., Cole, K.E., Smoot, D.T., et al. (1993) Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl Acad. Sci. USA, 90, 5123-5127.
24. Macé, K., Harris, C.C., Lipsky, M.M. and Pfeifer, A.M.A (1996) Human hepatocytes. In Freshney, R.I. and Freshney, M.G. (eds) Culture of Immortalized Cells. Wiley-Liss, New York, pp. 161-181.
25. Gomez-Lechon, M.J., Lopez, P., Donato, T., Montoya, A., Larrauri, A., Gimenez, P., Trullenque, R., Fabra, R. and Castell, J.V. (1990) Culture of human hepatocytes from small surgical liver biopsies. Biochemical characterization and comparison with in vivo. In Vitro Cell. Dev. Biol., 26, 67-74.
26. Macé, K., Vautravers, P., Granato, D., Gonzalez, F.J., Harris, C.C. and Pfeifer, A.M.A. (1997) Development of CYP450-expressing human bronchial epithelial cell lines for in vitro pharmacotoxicological applications. In Vitro Toxicol., 10, 85-92.
27. Donato, M.T., Castell, J.V. and Gomez-Lechon, M.J. (1995) Effect of model inducers on cytochrome P450 activities of human hepatocytes in primary culture. Drug Metab. Dispos., 23, 553-558.
28. Landegren, U. (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods, 67, 379-388.
29. 1-adducted DNA. Proc. Natl Acad. Sci. USA, 78, 5445-5449.
30. Aguilar, F. and Cerutti, P. (1996) Genotyping mutation assay (RFLP/PCR). In Pfeifer, G.P. (ed.) Technologies for Detection of DNA Damage and Mutations. Plenum Press, New York, pp. 431-438.
31. Offord, E.A., Macé, K., Avanti, O. and Pfeifer, A.M.A. (1997) Mechanisms involved in the chemoprotective effects of rosemary extract studied in human liver and bronchial cells. Cancer Lett., 114, 1-7.
32. 1. Cancer Res., 41, 197-203.
33. 1 and benzo(a)pyrene in animals and man at the DNA level. Int. Arch. Occup. Environ. Health, 60, 145-150.
34. 1-DNA adducts formed in vivo. Cancer Res., 48, 6328-6331.
35. 1 in rats at very low exposures. Cancer Res., 42, 3659-3662.
36. Eaton, D.L., Ramsdell, H.S. and Neal, G.E. (1994) Biotransformation of aflatoxins. In Eaton, D.L. and Groopman, J.D. (eds) The Toxicology of Aflatoxins. Academic Press Inc., San Diego, pp. 45-72.
37. Groopman, J.D., Cain, L.G. and Kensler, T.W. (1988) Aflatoxin exposure in human populations: measurements and relationships to cancer. CRC Crit. Rev. Toxicol., 19, 113-145.
38. Harrison, J.C. and Garner, R.C. (1991) Immunological and HPLC detection of aflatoxin adducts in human tissues after an acute poisoning incident in S.E. Asia. Carcinogenesis, 12, 741-743.
39. 1-DNA or -ribosomal RNA adducts formed in hepatic microsome mediated reactions in rat liver in vivo. Cancer Res., 37, 4430-4438.
40. Garner, R.C., Martin, C.N., Smith, J.R.L., Coles, B.F. and Tolson, M.R. (1979) Comparison of aflatoxin B1 and aflatoxin G1 binding to cellular macro-molecules in vitro, in vivo and after peracud oxidation: characterisation of the major nucleic acid adducts. Chem. Biol. Interact., 26, 57-73.
41. 1. Cancer Res., 54, 101-108.
42. 1: patterns of DNA adduct formation, removal and excretion in relation to carcinogenesis. Drug Metab. Rev., 13, 581-602.
43. McManus, M.E., Stupans, I., Ioanni, B., Burgess, W., Robson, R.A. and Birkett, D.J. (1988) Identification and quantitation in human liver of cytochromes P-450 analogous to rabbit cytochromes P-450 forms 4 and 6. Xenobiotica, 18, 207-216.
44. 1-DNA adduct. Proc. Natl Acad. Sci. USA, 93, 1535-1539.